(Q37253011)

19 August 2017

Dealing with heterogeneity of treatment effects: is the literature up to the challenge? (English)

1 reference

19 August 2017

1 reference

Richard L Kravitz

6

0 references

Joann Elmore

4

object named as

Joann G Elmore

1 reference

19 August 2017

Nicole B Gabler

1

1 reference

19 August 2017

Naihua Duan

2

1 reference

19 August 2017

Diana Liao

3

1 reference

19 August 2017

Theodore G Ganiats

5

1 reference

19 August 2017

language of work or name

English

0 references

publication date

19 June 2009

1 reference

19 August 2017

1 reference

19 August 2017

10

1 reference

19 August 2017

1

0 references

page(s)

43

1 reference

Creative Commons Attribution 2.0 Generic

19 August 2017

start time

19 June 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Heterogeneity of treatment effects: implications for guidelines, payment, and quality assessment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Treating individuals 3: from subgroups to individuals: general principles and the example of carotid endarterectomy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Individual response to treatment: is it a valid assumption?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Subgroup analysis in clinical trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Mediators and moderators of treatment effects in randomized clinical trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Forest plots: trying to see the wood and the trees

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Subgroups, treatment effects, and baseline risks: some lessons from major cardiovascular trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Subgroup analysis and other (mis)uses of baseline data in clinical trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Which medical journals have the greatest impact?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

A clinician's guide for conducting randomized trials in individual patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Heterogeneity of the baseline risk within patient populations of clinical trials: a proposed evaluation algorithm

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Statistics notes. Interaction 2: Compare effect sizes not P values

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Statistics in medicine--reporting of subgroup analyses in clinical trials.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Life and times of the impact factor: retrospective analysis of trends for seven medical journals (1994-2005) and their Editors' views.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Subgroup analyses in therapeutic cardiovascular clinical trials: are most of them misleading?

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Ethnic and racial differences in the smoking-related risk of lung cancer

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Controversies concerning randomization and additivity in clinical trials.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

A randomized trial of a single dose of oral dexamethasone for mild croup

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset?

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. European Carotid Surgery Trialists' Collaborative Group

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2706823

In pursuit of quality: the National Institute for Clinical Excellence

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1745-6215-10-43

Moderators of treatment outcomes: clinical, research, and policy importance

21 January 2018

1 reference

12 December 2020

Clinical application of pharmacogenetics

1 reference

12 December 2020

Reporting on methods of subgroup analysis in clinical trials: a survey of four scientific journals

1 reference

12 December 2020

An independently derived and validated predictive model for selecting patients with myocardial infarction who are likely to benefit from tissue plasminogen activator compared with streptokinase

1 reference

12 December 2020

Determining optimal therapy--randomized trials in individual patients

1 reference

12 December 2020

The use and abuse of subgroup analysis in epidemiological research

1 reference

12 December 2020

The ESPRIM trial: short-term treatment of acute myocardial infarction with molsidomine. European Study of Prevention of Infarct with Molsidomine (ESPRIM) Group

1 reference

12 December 2020

The problem of cogent subgroups: a clinicostatistical tragedy

1 reference

12 December 2020

Clinical versus statistical considerations in the design and analysis of clinical research

1 reference

12 December 2020

Selection bias and treatment heterogeneity in clinical trials

1 reference

12 December 2020

Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation

1 reference

12 December 2020

Beyond subgroup analysis: improving the clinical interpretation of treatment effects in stroke research

1 reference

12 December 2020

Reporting clinical trial results to inform providers, payers, and consumers

1 reference

12 December 2020

Identifiers

DOI

10.1186/1745-6215-10-43

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

19545379

1 reference